12.70Open12.70Pre Close0 Volume227 Open Interest65.00Strike Price0.00Turnover67.59%IV1.69%PremiumDec 20, 2024Expiry Date11.41Intrinsic Value100Multiplier3DDays to Expiry1.29Extrinsic Value100Contract SizeAmericanOptions Type0.9929Delta0.0039Gamma6.67Leverage Ratio-0.0173Theta0.0063Rho6.63Eff Leverage0.0015Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet